Clinical Trials Logo

Syndrome clinical trials

View clinical trials related to Syndrome.

Filter by:

NCT ID: NCT01464086 Completed - Clinical trials for Li Fraumeni Syndrome

LIFSCREEN : Evaluation of Whole Body MRI for Early Detection of Cancers in Subjects With P53 Mutation (Li-Fraumeni Syndrome)

LIFSCREEN
Start date: October 27, 2011
Phase: Phase 3
Study type: Interventional

The purpose of this study is to compare the diagnostic efficacy of two follow-up schedules for the early detection of cancers in the population under study on cancer incidence at 3 years.

NCT ID: NCT01463046 Completed - Clinical trials for Acute Myeloid Leukemia

Phase I Dose Finding and Proof-of-concept Study of Panobinostat With Standard Dose Cytarabine and Daunorubicin for Untreated Acute Myeloid Leukemia or Advanced Myelodysplastic Syndrome

Start date: January 2012
Phase: Phase 1
Study type: Interventional

The purpose of this study is to see if Panobinostat is safe to give to patients and to determine the best dose to give in combination with standard cytarabine and daunorubicin chemotherapy.

NCT ID: NCT01462864 Completed - Clinical trials for Polycystic Ovary Syndrome

Development of a Structured Education Programme for Women With Polycystic Ovary Syndrome

SUCCESS
Start date: September 2011
Phase: N/A
Study type: Interventional

Polycystic Ovary syndrome (PCOS) is a common hormonal imbalance affecting about 12% of women in the UK. The number of women with PCOS is rising. They suffer from a combination of symptoms including excess hair, irregular/absent periods, and infertility. About 70% of women with PCOS are obese or overweight, 10% develop type 2 diabetes (T2DM), and 30-40% have some degrees of abnormality in controlling (metabolising) blood sugar. Studies have shown that if women with PCOS make change to their lifestyle (diet and activity), they may reduce their risk of getting diabetes and heart disease in the future. This study aims to develop and test a programme that can be run in groups (structured education), to support women with PCOS make the lifestyle changes needed to improve their PCOS and prevent future associated health problems. Structured education programmes are suitable for use within the NHS and are already recommended for individuals with T2DM, but have not been tested as a method of treatment for PCOS which is a high risk condition for T2DM. The investigators aim to initially develop a specific education programme for women with PCOS using their expertise in their disease and defining their needs. The next step is to test this programme on 160 women with PCOS who will be selected from the investigators database or clinics. They will be divided randomly to two groups to receive either this programme or routine care. The investigators will give them an accelerometer (a very small portable device). This will measure their physical activity and counts their daily steps. The investigators aim is to increase their step count by at least 2000 steps per day after one year. The investigators believe that the group given the structured education will show some evidence of improvement in their glucose metabolism, and consequently decreased chance of developing diabetes.

NCT ID: NCT01462578 Completed - Clinical trials for Myelodysplastic Syndrome

Treatment of Patients With Myelodysplastic Syndrome or Acute Myelocytic Leukemia With an Impending Hematological Relapse With Azacitidine (Vidaza)

RELAZA2
Start date: September 2011
Phase: Phase 2
Study type: Interventional

Assessment of efficacy of azacitidine to prevent a relapse

NCT ID: NCT01459159 Terminated - Clinical trials for Myelodysplastic Syndrome (MDS)

Study of (Telintra®) in Non-Del(5q) Myelodysplastic Syndrome

Start date: October 2011
Phase: Phase 2
Study type: Interventional

This is a multicenter, single arm open label Phase 2b Study of oral ezatiostat (Telintra®) in Patients who are RBC tranfusion dependent, Low to INT-1 IPSS risk, non-del (5q) Myelodysplastic Syndrome (MDS).

NCT ID: NCT01457456 Withdrawn - Morquio B Disease Clinical Trials

Biomarker for Morquio Disease (BioMorquio)

BioMorquio
Start date: August 20, 2018
Phase:
Study type: Observational

Development of a new MS-based biomarker for the early and sensitive diagnosis of Morquio disease from plasma

NCT ID: NCT01457378 Completed - Clinical trials for Irritable Bowel Syndrome

Gastrointestinal Symptoms in Healthy Subjects and Patients With Irritable Bowel Syndrome

Start date: September 2011
Phase: N/A
Study type: Observational

The aim of this study performed in Irritable Bowel Syndrome (IBS) subjects and healthy patients is to demonstrate the ability of composite score of frequency of gastrointestinal symptoms to discriminate healthy subjects and IBS patients. The properties of this questionnaire of composite score of gastrointestinal symptoms frequency will be compared to other validated questionnaires (severity of IBS symptoms and HRQoL).

NCT ID: NCT01457209 Completed - Insulin Resistance Clinical Trials

Acupuncture to Treat Insulin Resistance in Women With and Without Polycystic Ovary Syndrome

PCOS-AcupIR
Start date: October 2011
Phase: Phase 1
Study type: Interventional

The central hypothesis is that acupuncture break the vicious circle of androgen excess and reverse insulin resistance and improve health related quality of life and affective symptoms in overweight and obese women with and without Polycystic Ovary Syndrome.

NCT ID: NCT01455168 Active, not recruiting - Clinical trials for Cataract With Exfoliation Syndrome

Efficacy of a Capsular Tension Ring in Preventing Anterior Capsule Shrinkage After Cataract Surgery in Exfoliation Syndrome

Effect of CTR
Start date: September 2004
Phase: Phase 3
Study type: Observational

The purpose of this study is to examine the efficacy of a capsular tension ring (CTR) in preventing anterior capsule shrinkage after cataract surgery in exfoliation syndrome (XFS) with no zonular weakness. The eyes with XFS undergo phacoemulsification and aspiration (PEA) with an intraocular lens (IOL) implantation. All operations are performed by a single surgeon. No eyes with either ectopia lentis or phacodonesis are included. There are three groups; CTR is not used in group A, CTR is simply implanted in group B, and CTR is implanted and closed by tying both eyelets in group C. The areas of continuous curvilinear capsulorhexis (CCC) are calculated, and both the time-course change and the comparison among the 3 groups are tested.

NCT ID: NCT01455012 Completed - Clinical trials for Restless Legs Syndrome

Effects of Neupro on Cardiovascular Observations in Patients With Restless Legs Syndrome

ENCORE
Start date: September 2011
Phase: Phase 4
Study type: Interventional

Periodic Limb Movements (PLMs) during sleep in patients with Restless Legs Syndrome (RLS) have been shown to be associated with elevations in Blood Pressure (BP). Rotigotine has been shown to effectively reduce the incidence of PLMs in patients with RLS. The current study aims to demonstrate that treatment with Rotigotine could help reduce the number of nocturnal BP elevations associated with PLMs in patients with RLS.